California Public Employees Retirement System’s AbbVie ABBV Stock Holding History

California Public Employees Retirement System’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$809M	Sell	3,720,076 -478,533	-11%	-$106M	0.5%	28
2025 Q4	$959M	Sell	4,198,609 -761,091	-15%	-$173M	0.55%	19
2025 Q3	$1.15B	Buy	4,959,700 +68,948	+1%	+$14M	0.69%	17
2025 Q2	$908M	Sell	4,890,752 -778,732	-14%	-$145M	0.58%	24
2025 Q1	$1.19B	Buy	5,669,484 +709,748	+14%	+$138M	0.83%	18
2024 Q4	$881M	Sell	4,959,736 -583,554	-11%	-$107M	0.59%	25
2024 Q3	$1.09B	Sell	5,543,290 -705,589	-11%	-$132M	0.77%	20
2024 Q2	$1.07B	Sell	6,248,879 -430,689	-6%	-$71.3M	0.79%	20
2024 Q1	$1.22B	Buy	6,679,568 +598,033	+10%	+$103M	0.86%	21
2023 Q4	$942M	Sell	6,081,535 -94,355	-2%	-$13.8M	0.72%	26
2023 Q3	$921M	Buy	6,175,890 +105,888	+2%	+$15.5M	0.79%	24
2023 Q2	$818M	Sell	6,070,002 -166,204	-3%	-$24.4M	0.7%	26
2023 Q1	$994M	Sell	6,236,206 -494,125	-7%	-$75.5M	0.88%	17
2022 Q4	$1.09B	Buy	6,730,331 +389,877	+6%	+$59.8M	0.93%	14
2022 Q3	$851M	Buy	6,340,454 +631,064	+11%	+$90.6M	0.78%	20
2022 Q2	$874M	Buy	5,709,390 +294,441	+5%	+$45M	0.82%	23
2022 Q1	$878M	Buy	5,414,949 +1,480,867	+38%	+$215M	0.68%	26
2021 Q4	$533M	Sell	3,934,082 -177,041	-4%	-$20.9M	0.36%	59
2021 Q3	$443M	Buy	4,111,123 +101,611	+3%	+$11.6M	0.33%	69
2021 Q2	$452M	Sell	4,009,512 -74,255	-2%	-$8.36M	0.34%	64
2021 Q1	$442M	Sell	4,083,767 -355,337	-8%	-$38M	0.34%	62
2020 Q4	$476M	Buy	4,439,104 +200,682	+5%	+$19.3M	0.37%	56
2020 Q3	$371M	Buy	4,238,422 +153,388	+4%	+$14.4M	0.33%	69
2020 Q2	$401M	Buy	4,085,034 +679,641	+20%	+$59.8M	0.4%	58
2020 Q1	$259M	Sell	3,405,393 -152,509	-4%	-$13M	0.31%	75
2019 Q4	$315M	Sell	3,557,902 -8,600	-0.2%	-$714K	0.29%	76
2019 Q3	$270M	Buy	3,566,502 +644,078	+22%	+$44.2M	0.27%	89
2019 Q2	$213M	Sell	2,922,424 -114,635	-4%	-$9.01M	0.25%	97
2019 Q1	$245M	Buy	3,037,059 +33,344	+1%	+$2.73M	0.3%	75
2018 Q4	$277M	Sell	3,003,715 -215,431	-7%	-$18.9M	0.39%	48
2018 Q3	$304M	Sell	3,219,146 -437,782	-12%	-$41.5M	0.39%	45
2018 Q2	$339M	Sell	3,656,928 -322,324	-8%	-$31.5M	0.47%	35
2018 Q1	$377M	Sell	3,979,252 -281,510	-7%	-$30.9M	0.54%	31
2017 Q4	$412M	Buy	4,260,762 +134,106	+3%	+$12.6M	0.56%	31
2017 Q3	$367M	Buy	4,126,656 +177,027	+4%	+$13.5M	0.54%	32
2017 Q2	$286M	Buy	3,949,629 +59,900	+2%	+$4.03M	0.46%	38
2017 Q1	$253M	Sell	3,889,729 -100,200	-3%	-$6.3M	0.41%	39
2016 Q4	$250M	Sell	3,989,929 -57,200	-1%	-$3.49M	0.42%	39
2016 Q3	$255M	Sell	4,047,129 -434,400	-10%	-$28.1M	0.42%	42
2016 Q2	$277M	Buy	4,481,529 +243,300	+6%	+$14.8M	0.45%	43
2016 Q1	$242M	Sell	4,238,229 -128,700	-3%	-$7.17M	0.39%	46
2015 Q4	$259M	Sell	4,366,929 -29,700	-0.7%	-$1.71M	0.41%	45
2015 Q3	$239M	Sell	4,396,629 -115,100	-3%	-$7.49M	0.41%	44
2015 Q2	$303M	Buy	4,511,729 +330,659	+8%	+$21.6M	0.46%	39
2015 Q1	$264M	Hold	4,181,070	–	–	0.36%	47
2014 Q4	$264M	Sell	4,181,070 -383,216	-8%	-$24.2M	0.36%	47
2014 Q3	$264M	Sell	4,564,286 -21,554	-0.5%	-$1.2M	0.36%	52
2014 Q2	$259M	Buy	4,585,840 +205,472	+5%	+$10.8M	0.35%	49
2014 Q1	$215M	Sell	4,380,368 -215,612	-5%	-$10.9M	0.31%	57
2013 Q4	$244M	Buy	4,595,980 +404,997	+10%	+$19.9M	0.35%	52
2013 Q3	$187M	Buy	4,190,983 +37,716	+0.9%	+$1.67M	0.35%	51
2013 Q2	$172M	Buy	+4,153,267	New	+$182M	0.34%	50

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

California Public Employees Retirement System's ABBV Position: Q1 2026 in Review

California Public Employees Retirement System reduced its AbbVie (ABBV) stake by 11% in Q1 2026, selling an estimated $106M and leaving 3,720,076 shares worth $809M. The position accounts for 0.5% of the portfolio, ranked #28.

California Public Employees Retirement System first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.22B in Q1 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

California Public Employees Retirement System held 3,720,076 shares of AbbVie worth $809M as of Q1 2026.
California Public Employees Retirement System sold 478,533 AbbVie shares in Q1 2026, an estimated $106M.
AbbVie made up 0.5% of California Public Employees Retirement System's portfolio in Q1 2026, its #28 holding.
California Public Employees Retirement System first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
California Public Employees Retirement System's AbbVie position peaked at $1.22B in Q1 2024.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on California Public Employees Retirement System's 13F filing for Q1 2026, filed 6 May 2026.